Sagimet Biosciences Inc. (SGMT) Earnings Per Share (EPS)
Sagimet Biosciences Inc. (SGMT) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2021-12-31 | N/A |
| 2022-12-31 | -$165.20 |
| 2023-12-31 | -$2.66 |
| 2024-12-31 | -$1.45 |
| 2025-12-31 | -$1.58 |
How SGMT compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| TENX | — | -$1.34 |
| OCUL | Ocular Therapeutix Inc. | -$1.42 |
| RLMD | Relmada Therapeutics Inc. | -$1.45 |
| INO | Inovio Pharmaceuticals Inc. | -$1.81 |
| VTGN | Vistagen Therapeutics Inc. | -$1.83 |
These are five companies in the same sector as SGMT with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Sagimet Biosciences Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("SGMT")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SGMT | $10.55 | +0.00% | 0.97M |
| 3 | ||||
| 4 | ||||
| 5 |